FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987519487> ?p ?o ?g. }

• W2987519487 abstract "This proposed study will examine whether structured physical activity reduces the recovery time of cognitive functioning during the early phase of substance use disorder treatment. Addiction or substance dependence is associated with neurobiological changes and cognitive impairment that can affect quality of life and the efficacy of therapy for up to a year after clinical detoxification. The biological, psychological, and social effects of physical exercise have the potential to be a therapeutic approach to increase quality of life and relieve symptoms associated with substance abuse, such as psychosis, depression, and anxiety. There is a dearth of research on physical activity and exercise in clinical substance use disorder patients. This protocol describes a clinical study that will examine cognitive recovery after substance abuse using physical exercise as a treatment intervention. We will use a quasi-experimental longitudinal clinical trial, with a pretest and multiple posttests, on naturally randomized sequential groups. Patients will be consecutively be recruited into the study groups, with a control group that is completed, before its followed by an intervention group, each with 30 patients. Patients will be enrolled 2 weeks after the start of detoxification, at which time all subjects will be inpatients at the Stavanger Salvation Army Treatment Center in the Norwegian specialized healthcare system. Cognition will be evaluated with a comprehensive battery of cognitive tests, including several tests of executive function. Physical fitness will be tested with the Rockport 1-Mile Walk Test, the 30-S Chair Stand Test, the 1-Min Burpee Test at baseline (within the first 2 weeks of admittance) and after 4 weeks. The intervention will be a 30-min workout at 70-90% of maximum heart rate (134-170 bpm), recorded and calculated by a Polar heart rate monitor. The intervention treatment will be administered four times a week for 4 weeks and will consist of high-intensity circuit training, high-intensity interval training, functional movement, and primitive reflex training. We anticipate improvement in both the control and intervention groups, with the exercise intervention group having the greatest increase in recovery of cognitive function because of the combination of functional full body movements and primitive movement training in an intense interval training program. Clinical Trial Registration ID: ISRCTN74750479, Retrospectively Registered." @default.
• W2987519487 created "2019-11-22" @default.
• W2987519487 creator A5001072999 @default.
• W2987519487 creator A5002609308 @default.
• W2987519487 creator A5032443209 @default.
• W2987519487 creator A5037565150 @default.
• W2987519487 creator A5071430080 @default.
• W2987519487 date "2019-11-15" @default.
• W2987519487 modified "2023-10-14" @default.
• W2987519487 title "The Effect of High-Intensity Interval/Circuit Training on Cognitive Functioning and Quality of Life During Recovery From Substance Abuse Disorder. A Study Protocol" @default.
• W2987519487 cites W1558792767 @default.
• W2987519487 cites W1731053727 @default.
• W2987519487 cites W178800575 @default.
• W2987519487 cites W1903472121 @default.
• W2987519487 cites W1928207405 @default.
• W2987519487 cites W1967890944 @default.
• W2987519487 cites W1975579264 @default.
• W2987519487 cites W1982444398 @default.
• W2987519487 cites W1983182638 @default.
• W2987519487 cites W1983649795 @default.
• W2987519487 cites W1986215215 @default.
• W2987519487 cites W1990882670 @default.
• W2987519487 cites W1993455459 @default.
• W2987519487 cites W2001617445 @default.
• W2987519487 cites W2005093864 @default.
• W2987519487 cites W2009578511 @default.
• W2987519487 cites W2011160896 @default.
• W2987519487 cites W2013615708 @default.
• W2987519487 cites W2015278509 @default.
• W2987519487 cites W2020555733 @default.
• W2987519487 cites W2023551388 @default.
• W2987519487 cites W2025999375 @default.
• W2987519487 cites W2031122668 @default.
• W2987519487 cites W2036886147 @default.
• W2987519487 cites W2041598613 @default.
• W2987519487 cites W2043358844 @default.
• W2987519487 cites W2052484093 @default.
• W2987519487 cites W2054764555 @default.
• W2987519487 cites W2059057223 @default.
• W2987519487 cites W2064637992 @default.
• W2987519487 cites W2069376444 @default.
• W2987519487 cites W2083205008 @default.
• W2987519487 cites W2087555015 @default.
• W2987519487 cites W2087969867 @default.
• W2987519487 cites W2099917845 @default.
• W2987519487 cites W2102461536 @default.
• W2987519487 cites W2103318471 @default.
• W2987519487 cites W2110524682 @default.
• W2987519487 cites W2128056662 @default.
• W2987519487 cites W2140338126 @default.
• W2987519487 cites W2144269887 @default.
• W2987519487 cites W2146980963 @default.
• W2987519487 cites W2147545294 @default.
• W2987519487 cites W2156044731 @default.
• W2987519487 cites W2162363996 @default.
• W2987519487 cites W2165412923 @default.
• W2987519487 cites W2165758561 @default.
• W2987519487 cites W2168905331 @default.
• W2987519487 cites W2227813149 @default.
• W2987519487 cites W2293895912 @default.
• W2987519487 cites W2334943386 @default.
• W2987519487 cites W2335965827 @default.
• W2987519487 cites W2401304833 @default.
• W2987519487 cites W2416209079 @default.
• W2987519487 cites W2507368141 @default.
• W2987519487 cites W2514214628 @default.
• W2987519487 cites W2571910151 @default.
• W2987519487 cites W2583514352 @default.
• W2987519487 cites W2605039992 @default.
• W2987519487 cites W2605376995 @default.
• W2987519487 cites W2613914741 @default.
• W2987519487 cites W2675634400 @default.
• W2987519487 cites W2746570741 @default.
• W2987519487 cites W2750011131 @default.
• W2987519487 cites W2751524273 @default.
• W2987519487 cites W2900828899 @default.
• W2987519487 cites W3124410800 @default.
• W2987519487 cites W4212967650 @default.
• W2987519487 doi "https://doi.org/10.3389/fpsyg.2019.02564" @default.
• W2987519487 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6873325" @default.
• W2987519487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31803108" @default.
• W2987519487 hasPublicationYear "2019" @default.
• W2987519487 type Work @default.
• W2987519487 sameAs 2987519487 @default.
• W2987519487 citedByCount "6" @default.
• W2987519487 countsByYear W29875194872020 @default.
• W2987519487 countsByYear W29875194872021 @default.
• W2987519487 countsByYear W29875194872023 @default.
• W2987519487 crossrefType "journal-article" @default.
• W2987519487 hasAuthorship W2987519487A5001072999 @default.
• W2987519487 hasAuthorship W2987519487A5002609308 @default.
• W2987519487 hasAuthorship W2987519487A5032443209 @default.
• W2987519487 hasAuthorship W2987519487A5037565150 @default.
• W2987519487 hasAuthorship W2987519487A5071430080 @default.
• W2987519487 hasBestOaLocation W29875194871 @default.
• W2987519487 hasConcept C118552586 @default.
• W2987519487 hasConcept C141071460 @default.
• W2987519487 hasConcept C15744967 @default.
• W2987519487 hasConcept C168563851 @default.
• W2987519487 hasConcept C169900460 @default.

• next